Ami Fadia
Stock Analyst at Needham
(3.38)
# 928
Out of 4,784 analysts
407
Total ratings
42.98%
Success rate
3.86%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMRX Immuneering | Reiterates: Buy | $12 | $1.64 | +631.71% | 14 | Mar 21, 2025 | |
| BCYC Bicycle Therapeutics | Reiterates: Buy | $30 | $8.97 | +234.45% | 18 | Mar 11, 2025 | |
| JAZZ Jazz Pharmaceuticals | Reiterates: Buy | $210 | $122.92 | +70.84% | 28 | Mar 5, 2025 | |
| AVDL Avadel Pharmaceuticals | Reiterates: Buy | $19 | $8.01 | +137.20% | 34 | Mar 4, 2025 | |
| NMRA Neumora Therapeutics | Reiterates: Buy | $5 | $1.03 | +385.44% | 7 | Mar 4, 2025 | |
| AXSM Axsome Therapeutics | Reiterates: Buy | $153 | $118.53 | +29.08% | 13 | Mar 3, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $150 → $85 | $38.66 | +119.87% | 9 | Mar 3, 2025 | |
| MRUS Merus | Maintains: Buy | $85 → $83 | $44.61 | +86.06% | 26 | Feb 28, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $28 | $17.07 | +64.03% | 7 | Feb 27, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $60 → $59 | $37.35 | +57.97% | 21 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $6.48 | - | 22 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $8.07 | +296.53% | 19 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $33.19 | +50.65% | 33 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $131.81 | - | 27 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $133 | $88.72 | +49.91% | 28 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $138.37 | - | 37 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $8.28 | - | 19 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $113.16 | - | 12 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $16 | $0.44 | +3,534.71% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $63 → $75 | $24.91 | +201.08% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $23 | $1.26 | +1,685.71% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $63 | $28.06 | +124.52% | 5 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $12 → $5 | $2.78 | +80.18% | 2 | Jan 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $15.08 | - | 9 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $2.26 | +873.45% | 4 | Jan 3, 2018 | |
Immuneering
Mar 21, 2025
Reiterates: Buy
Price Target: $12
Current: $1.64
Upside: +631.71%
Bicycle Therapeutics
Mar 11, 2025
Reiterates: Buy
Price Target: $30
Current: $8.97
Upside: +234.45%
Jazz Pharmaceuticals
Mar 5, 2025
Reiterates: Buy
Price Target: $210
Current: $122.92
Upside: +70.84%
Avadel Pharmaceuticals
Mar 4, 2025
Reiterates: Buy
Price Target: $19
Current: $8.01
Upside: +137.20%
Neumora Therapeutics
Mar 4, 2025
Reiterates: Buy
Price Target: $5
Current: $1.03
Upside: +385.44%
Axsome Therapeutics
Mar 3, 2025
Reiterates: Buy
Price Target: $153
Current: $118.53
Upside: +29.08%
Praxis Precision Medicines
Mar 3, 2025
Maintains: Buy
Price Target: $150 → $85
Current: $38.66
Upside: +119.87%
Merus
Feb 28, 2025
Maintains: Buy
Price Target: $85 → $83
Current: $44.61
Upside: +86.06%
ACADIA Pharmaceuticals
Feb 27, 2025
Reiterates: Buy
Price Target: $28
Current: $17.07
Upside: +64.03%
Revolution Medicines
Feb 27, 2025
Maintains: Buy
Price Target: $60 → $59
Current: $37.35
Upside: +57.97%
Feb 26, 2025
Reiterates: Hold
Price Target: n/a
Current: $6.48
Upside: -
Feb 26, 2025
Reiterates: Buy
Price Target: $32
Current: $8.07
Upside: +296.53%
Feb 26, 2025
Reiterates: Buy
Price Target: $50
Current: $33.19
Upside: +50.65%
Feb 21, 2025
Reiterates: Hold
Price Target: n/a
Current: $131.81
Upside: -
Feb 14, 2025
Reiterates: Buy
Price Target: $133
Current: $88.72
Upside: +49.91%
Feb 13, 2025
Reiterates: Hold
Price Target: n/a
Current: $138.37
Upside: -
Feb 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $8.28
Upside: -
Feb 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $113.16
Upside: -
Feb 1, 2021
Maintains: Outperform
Price Target: $12 → $16
Current: $0.44
Upside: +3,534.71%
Jan 21, 2021
Downgrades: Market Perform
Price Target: $63 → $75
Current: $24.91
Upside: +201.08%
Oct 1, 2020
Maintains: Market Perform
Price Target: $15 → $23
Current: $1.26
Upside: +1,685.71%
Sep 17, 2020
Maintains: Outperform
Price Target: $64 → $63
Current: $28.06
Upside: +124.52%
Jan 30, 2019
Downgrades: Market Perform
Price Target: $12 → $5
Current: $2.78
Upside: +80.18%
Oct 1, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $15.08
Upside: -
Jan 3, 2018
Initiates: Outperform
Price Target: $22
Current: $2.26
Upside: +873.45%